الولايات المتحدة · وكالات وأخبار لحظية · Bloomberg

Boehringer, Sino Enter Cancer Drug Deal Worth Over $7 Billion

نشره Bloomberg · الولايات المتحدة منذ 1 س

Boehringer Ingelheim GmbH signed a licensing deal potentially worth more than $7 billion with China’s Sino Biopharmaceutical Limited and its subsidiaries for experimental cancer…

اقرأ المقال كاملًا على Bloomberg سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.bloomberg.com)

يستحق القراءة أيضًا

PR Newswire

Energy Fuels Announces Appointment of Jeffrey Olsen to Board of Directors

Associated Press (Business)

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

MT Newswires

Boehringer, Sino Enter Cancer Drug Deal Worth Over $7 Billion

مشاركة

يستحق القراءة أيضًا

Energy Fuels Announces Appointment of Jeffrey Olsen to Board of Directors

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot